Kuan Hu Selected Research

1-methyl-L-tryptophan

1/2021

Off-tumor IDO1 target engagements determine the cancer-immune set point and predict the immunotherapeutic efficacy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kuan Hu Research Topics

Disease

29	Neoplasms (Cancer) 06/2022 - 04/2016
10	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 12/2014
8	Neoplasm Metastasis (Metastasis) 06/2022 - 12/2014
6	Infections 05/2022 - 04/2015
3	Tuberculosis (Tuberculoses) 05/2022 - 04/2015
3	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2017
3	Cholangiocarcinoma 01/2021 - 03/2020
3	Hypoxia (Hypoxemia) 12/2020 - 11/2016
2	Breast Neoplasms (Breast Cancer) 06/2022 - 11/2017
2	Inflammation (Inflammations) 01/2022 - 10/2020
2	Melanoma (Melanoma, Malignant) 01/2021 - 01/2020
2	Carcinoma (Carcinomatosis) 01/2021 - 02/2020
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2017
2	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2019
2	Schizophrenia (Dementia Praecox) 01/2020 - 01/2019
2	Substance-Related Disorders (Drug Abuse) 01/2020 - 10/2019
2	Brain Diseases (Brain Disorder) 01/2020 - 05/2019
2	Liver Diseases (Liver Disease) 12/2019 - 05/2019
2	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2019 - 01/2019
2	Teratocarcinoma 07/2017 - 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2022
1	Glioma (Gliomas) 01/2021
1	Thrombosis (Thrombus) 01/2021
1	Endometrial Neoplasms (Endometrial Cancer) 01/2021
1	Carcinogenesis 01/2021
1	Overweight 02/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Cysts 12/2019

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2015
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2018
7	Peptides (Polypeptides)IBA 05/2022 - 01/2017
4	Proteasome Endopeptidase Complex (Proteasome)IBA 07/2017 - 04/2015
3	PolymersIBA 06/2022 - 07/2017
3	Biological ProductsIBA 05/2022 - 01/2017
3	Small Interfering RNA (siRNA)IBA 08/2019 - 01/2017
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2017
2	RadiopharmaceuticalsIBA 01/2021 - 01/2020
2	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 01/2019
2	camrelizumabIBA 01/2021 - 10/2019
2	Radioisotopes (Radionuclides)IBA 01/2021 - 01/2020
2	Phosphorus (Red Phosphorus)IBA 01/2020 - 07/2017
1	Tyrosine Kinase InhibitorsIBA 07/2022
1	ErbB Receptors (EGF Receptor)IBA 07/2022
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2022
1	HydrogelsIBA 06/2022
1	MagnesiumIBA 06/2022
1	Polyvinyl AlcoholIBA 06/2022
1	Immune Checkpoint InhibitorsIBA 06/2022
1	PolyethyleneimineIBA 06/2022
1	PolyaminesIBA 06/2022
1	Dexmedetomidine FDA Link 01/2022
1	Aminocaproic Acid (6 Aminocaproic Acid)FDA LinkGeneric 01/2022
1	TARPIBA 01/2022
1	GasderminsIBA 11/2021
1	Hypoxia-Inducible Factor 1IBA 10/2021
1	erdafitinibIBA 01/2021
1	1-methyl-L-tryptophanIBA 01/2021
1	alantolactoneIBA 01/2021
1	6-methyladenineIBA 01/2021
1	gastric inhibitory polypeptide receptorIBA 01/2021
1	Temozolomide (Temodar)FDA LinkGeneric 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	AntibodiesIBA 01/2021
1	Plant ExtractsIBA 01/2021
1	TitaniumIBA 01/2021
1	Tumor Biomarkers (Tumor Markers)IBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2021
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 01/2021
1	64Cu- cyclam- RAFT- cyclo(arginyl- glycyl- aspartyl- phenylalanyl- lysyl)4IBA 12/2020
1	IntegrinsIBA 12/2020
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2020
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 03/2020
1	2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a (HPPH)IBA 02/2020
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 02/2020
1	pyridineIBA 01/2020
1	Long Noncoding RNAIBA 01/2020
1	N-methylbenzamideIBA 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020
1	plexinIBA 01/2020
1	Oncogene Proteins (Oncogene Protein)IBA 01/2020
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2020
1	metabotropic glutamate receptor type 1IBA 01/2020
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2020
1	metabotropic glutamate receptor 2IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Wiskott-Aldrich Syndrome Protein FamilyIBA 01/2020

Therapy/Procedure

12	Therapeutics 01/2021 - 01/2017
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2019
2	Immunomodulation 06/2022 - 01/2021
2	Radiotherapy 01/2021 - 12/2020
2	Hepatectomy 12/2019 - 01/2019
1	Immunotherapy 01/2021
1	Precision Medicine 01/2021
1	Photothermal Therapy 01/2020
1	Intravenous Injections 01/2020
1	Sclerotherapy 12/2019